KASEY BRUNDIDGE: Open Payments
NPI 1669676961 · ADA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 32 payments from 8 companies in 2025. Trend: 2023 $368 · 2024 $390 · 2025 $2,167
Travel & lodging: $1,462Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $1,746 |
| Novo Nordisk Inc | 10 | $158 |
| Corcept Therapeutics | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| ABBVIE INC. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lilly USA, LLC | 1 | $16 |
Products named: FARAPULSE, Korlym, Ozempic, Rybelsus, FARXIGA, VRAYLAR, Saxenda, REXULTI.
Industry payments across OK — which companies pay providers there.
